AI-generated summary
In this pilot uncontrolled trial, the authors treated 14 patients with mild cognitive impairment using photobiomodulation over the vertebral and internal carotid arteries and measured cognition and regional cerebral blood flow before and after treatment. They report statistically significant changes in blood flow in several brain regions and in some cognitive measures, which they associate with the treatment. The authors state that a larger study is needed to validate these findings.
- Participants
- 14
- Who or what was studied
- Patients with mild cognitive impairment
- Limits stated in the abstract
- The trial was a small pilot study without a control group, and the authors state that a larger sample size is needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Cerebral blood flow, Mild cognitive impairment, Nitric oxide, Sample size, Photon. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.